Details of the Drug Reposition

General Information of This Drug (ID: DMDU5Y2)

Drug Name
QPI-1002   DMDU5Y2
Therapeutic Class
siRNA
Drug Type
siRNA drug

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
1 Phase 3 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Renal transplantation DISVLUUA NE84 Phase 3 [1]
------------------------------------------------------------------------------------
1 Phase 1/2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Renal artery disease DISDXEOY BD40.2 Phase 1/2 [2]
------------------------------------------------------------------------------------

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 ClinicalTrials.gov (NCT00802347) I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation. U.S. National Institutes of Health.